Latest News
|
More Articles...
- Milestone Pharmaceuticals Progresses Clinical and Regulatory Activities for Etripamil in Patients with Paroxysmal Supraventricular Tachycardia
- Conformal Medical Announces Positive One-Year Data from its Left Atrial Appendage Closure Performed Under Conscious Sedation Study
- Study Demonstrates Successful Device Size Selection When Assessing Left Atrial Appendage by Angiography Compared to TEE
- Varian Receives Investigational Device Exemption for Cardiac Radioablation Clinical Trial, RADIATE-VT
- BIOTRONIK Enrolls First Patient Into BIO-CONDUCT, First IDE Trial to Study Use of Stylet-Driven Leads for Conduction System Pacing
- CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
- CardiacSense receives FDA Clearance for Medical Watch
- Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation and 3D Mapping & Navigation for Treatment of Cardiac Arrhythmias
- JSCAI Publishes Peer-Reviewed Article Highlighting Effective Performance of Conformal Medical’s Left Atrial Appendage (CLAAS®) Device
- Maxwell Biomedical Completes Acquisition of Cardialen’s Assets
|
|
